company background image
S1TE34 logo

STERIS BOVESPA:S1TE34 Stock Report

Last Price

R$63.72

Market Cap

R$132.7b

7D

0%

1Y

n/a

Updated

10 Mar, 2025

Data

Company Financials +

S1TE34 Stock Overview

Provides infection prevention products and services worldwide. More details

S1TE34 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance2/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

STERIS plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for STERIS
Historical stock prices
Current Share PriceUS$63.72
52 Week HighUS$67.27
52 Week LowUS$53.05
Beta0.92
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change14.17%
5 Year Changen/a
Change since IPO21.46%

Recent News & Updates

Recent updates

Shareholder Returns

S1TE34BR Medical EquipmentBR Market
7D0%-4.4%1.2%
1Yn/a2.0%-8.4%

Return vs Industry: Insufficient data to determine how S1TE34 performed against the BR Medical Equipment industry.

Return vs Market: Insufficient data to determine how S1TE34 performed against the BR Market.

Price Volatility

Is S1TE34's price volatile compared to industry and market?
S1TE34 volatility
S1TE34 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.0%
Market Average Movement5.3%
10% most volatile stocks in BR Market9.7%
10% least volatile stocks in BR Market3.0%

Stable Share Price: S1TE34's share price has been volatile over the past 3 months compared to the BR market.

Volatility Over Time: Insufficient data to determine S1TE34's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
198518,000Dan Carestiowww.steris.com

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.

STERIS plc Fundamentals Summary

How do STERIS's earnings and revenue compare to its market cap?
S1TE34 fundamental statistics
Market capR$132.66b
Earnings (TTM)R$3.58b
Revenue (TTM)R$31.32b

37.1x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
S1TE34 income statement (TTM)
RevenueUS$5.40b
Cost of RevenueUS$3.03b
Gross ProfitUS$2.37b
Other ExpensesUS$1.75b
EarningsUS$616.59m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)6.28
Gross Margin43.81%
Net Profit Margin11.42%
Debt/Equity Ratio33.7%

How did S1TE34 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

35%

Payout Ratio

Does S1TE34 pay a reliable dividends?

See S1TE34 dividend history and benchmarks
When do you need to buy S1TE34 by to receive an upcoming dividend?
STERIS dividend dates
Ex Dividend DateFeb 19 2025
Dividend Pay DateMar 27 2025
Days until Ex dividend20 days
Days until Dividend pay date16 days

Does S1TE34 pay a reliable dividends?

See S1TE34 dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/10 05:55
End of Day Share Price 2025/01/20 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

STERIS plc is covered by 25 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Michael PolarkBaird
Erin Wilson WrightBofA Global Research